Keywords: Ranbaxy, Daiichi Sankyo, Mexico, Licensing

Ranbaxy unit to commercialize Daiichi Sankyo drugs in Mexico

Article | 12 October 2009

Print This

Japanese drug major Daiichi Sankyo’s portfolio of drugs is to be commercialized in Mexico through a recently created marketing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in